Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Down 62.6% in January

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 10,400 shares, a drop of 62.6% from the December 31st total of 27,800 shares. Based on an average daily trading volume, of 273,300 shares, the days-to-cover ratio is currently 0.0 days.

Biodexa Pharmaceuticals Stock Down 0.2 %

NASDAQ BDRX traded down $0.01 on Thursday, hitting $4.24. 3,685 shares of the stock were exchanged, compared to its average volume of 14,383. Biodexa Pharmaceuticals has a 52-week low of $3.50 and a 52-week high of $74.00. The business has a fifty day moving average price of $4.50.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.